← FDA DRUG APPROVALS

FDA ANDA · ANDA085797

NITROFURANTOIN

Sponsor: WATSON LABS

APPLICATION
ANDA085797
TYPE
ANDA
ORIGINAL APPROVAL
1978-12-05
LATEST ACTION
1989-02-08
ROUTE
ORAL
DOSAGE FORM
TABLET
MARKETING STATUS
Discontinued

Products

NITROFURANTOINDiscontinued
NITROFURANTOIN 50MG · TABLET · ORAL

Approval history

1989-02-08Labeling · Supplement 17AP
1978-12-05OriginalAP
VIEW ON DRUGS@FDA ↗

Related on SPEQ

Pharma industryGMP disciplineFDA drug shortagesFDA enforcement & recalls

Source: FDA Drugs@FDA. SPEQ is not affiliated with the FDA; this is a reference view of public FDA data, not medical, legal, or regulatory advice.

Weekly Briefing

Get the Weekly GxP Briefing

Curated regulatory intelligence — enforcement, recalls, guidance, and quality signals — in one practitioner-grade email each week. Free.

Read a past issue →